Century Therapeutics, Inc. (IPSC) vs SAB Biotherapeutics, Inc. (SABS)
Century Therapeutics, Inc. and SAB Biotherapeutics, Inc. are both Biotechnology companies. Century Therapeutics, Inc. and SAB Biotherapeutics, Inc. are of similar size ($306.0M and $304.8M). Century Therapeutics, Inc. grew revenue faster over the last twelve months: 8,286.7% against −60.3%. Across the 14 metrics below, SAB Biotherapeutics, Inc. leads on 8 and Century Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | IPSC | SABS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (49.65%) | (19.21%) | (57.72%) |
| Return on assets | (38.41%) | (16.24%) | (49.22%) |
| Return on invested capital | (64.92%) | (38.97%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack